333 related articles for article (PubMed ID: 30215111)
1. Current concepts and challenges in the radiologic assessment of brain tumors in children: part 2.
Tamrazi B; Mankad K; Nelson M; D'Arco F
Pediatr Radiol; 2018 Dec; 48(13):1844-1860. PubMed ID: 30215111
[TBL] [Abstract][Full Text] [Related]
2. Current concepts in radiologic assessment of pediatric brain tumors during treatment, part 1.
D'Arco F; Culleton S; De Cocker LJL; Mankad K; Davila J; Tamrazi B
Pediatr Radiol; 2018 Dec; 48(13):1833-1843. PubMed ID: 29980859
[TBL] [Abstract][Full Text] [Related]
3. Neuroimaging of Peptide-based Vaccine Therapy in Pediatric Brain Tumors: Initial Experience.
Furtado AD; Ceschin R; Blüml S; Mason G; Jakacki RI; Okada H; Pollack IF; Panigrahy A
Neuroimaging Clin N Am; 2017 Feb; 27(1):155-166. PubMed ID: 27889021
[TBL] [Abstract][Full Text] [Related]
4. Current Clinical Brain Tumor Imaging.
Villanueva-Meyer JE; Mabray MC; Cha S
Neurosurgery; 2017 Sep; 81(3):397-415. PubMed ID: 28486641
[TBL] [Abstract][Full Text] [Related]
5. Treatment-related changes in glioblastoma: a review on the controversies in response assessment criteria and the concepts of true progression, pseudoprogression, pseudoresponse and radionecrosis.
Delgado-López PD; Riñones-Mena E; Corrales-García EM
Clin Transl Oncol; 2018 Aug; 20(8):939-953. PubMed ID: 29218626
[TBL] [Abstract][Full Text] [Related]
6. An Update on the Approach to the Imaging of Brain Tumors.
Mullen KM; Huang RY
Curr Neurol Neurosci Rep; 2017 Jul; 17(7):53. PubMed ID: 28516376
[TBL] [Abstract][Full Text] [Related]
7. Advanced MR Imaging in Pediatric Brain Tumors, Clinical Applications.
Lequin M; Hendrikse J
Neuroimaging Clin N Am; 2017 Feb; 27(1):167-190. PubMed ID: 27889022
[TBL] [Abstract][Full Text] [Related]
8. Physiologic MRI for assessment of response to therapy and prognosis in glioblastoma.
Shiroishi MS; Boxerman JL; Pope WB
Neuro Oncol; 2016 Apr; 18(4):467-78. PubMed ID: 26364321
[TBL] [Abstract][Full Text] [Related]
9. Perfusion MRI in treatment evaluation of glioblastomas: Clinical relevance of current and future techniques.
van Dijken BRJ; van Laar PJ; Smits M; Dankbaar JW; Enting RH; van der Hoorn A
J Magn Reson Imaging; 2019 Jan; 49(1):11-22. PubMed ID: 30561164
[TBL] [Abstract][Full Text] [Related]
10. Imaging of the Posttherapeutic Brain.
Telles BA; D'Amore F; Lerner A; Law M; Shiroishi MS
Top Magn Reson Imaging; 2015 Jun; 24(3):147-54. PubMed ID: 26049818
[TBL] [Abstract][Full Text] [Related]
11. Anatomical and functional MR imaging to define tumoral boundaries and characterize lesions in neuro-oncology.
Benzakoun J; Robert C; Legrand L; Pallud J; Meder JF; Oppenheim C; Dhermain F; Edjlali M
Cancer Radiother; 2020 Aug; 24(5):453-462. PubMed ID: 32278653
[TBL] [Abstract][Full Text] [Related]
12. Response Assessment in Neuro-Oncology Criteria and Clinical Endpoints.
Huang RY; Wen PY
Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):705-718. PubMed ID: 27742111
[TBL] [Abstract][Full Text] [Related]
13. Taming Glioblastoma in "Real Time": Integrating Multimodal Advanced Neuroimaging/AI Tools Towards Creating a Robust and Therapy Agnostic Model for Response Assessment in Neuro-Oncology.
de Godoy LL; Chawla S; Brem S; Mohan S
Clin Cancer Res; 2023 Jul; 29(14):2588-2592. PubMed ID: 37227179
[TBL] [Abstract][Full Text] [Related]
14. Neuroimaging of pediatric brain tumors: from basic to advanced magnetic resonance imaging (MRI).
Panigrahy A; Blüml S
J Child Neurol; 2009 Nov; 24(11):1343-65. PubMed ID: 19841424
[TBL] [Abstract][Full Text] [Related]
15. Advanced imaging techniques for neuro-oncologic tumor diagnosis, with an emphasis on PET-MRI imaging of malignant brain tumors.
Overcast WB; Davis KM; Ho CY; Hutchins GD; Green MA; Graner BD; Veronesi MC
Curr Oncol Rep; 2021 Feb; 23(3):34. PubMed ID: 33599882
[TBL] [Abstract][Full Text] [Related]
16. Imaging Glioblastoma Posttreatment: Progression, Pseudoprogression, Pseudoresponse, Radiation Necrosis.
Strauss SB; Meng A; Ebani EJ; Chiang GC
Neuroimaging Clin N Am; 2021 Feb; 31(1):103-120. PubMed ID: 33220823
[TBL] [Abstract][Full Text] [Related]
17. Metabolic and physiologic magnetic resonance imaging in distinguishing true progression from pseudoprogression in patients with glioblastoma.
Chawla S; Bukhari S; Afridi OM; Wang S; Yadav SK; Akbari H; Verma G; Nath K; Haris M; Bagley S; Davatzikos C; Loevner LA; Mohan S
NMR Biomed; 2022 Jul; 35(7):e4719. PubMed ID: 35233862
[TBL] [Abstract][Full Text] [Related]
18. Progress in neuro-imaging of brain tumors.
Castellano A; Falini A
Curr Opin Oncol; 2016 Nov; 28(6):484-493. PubMed ID: 27649026
[TBL] [Abstract][Full Text] [Related]
19. Advanced Imaging Techniques for Differentiating Pseudoprogression and Tumor Recurrence After Immunotherapy for Glioblastoma.
Li Y; Ma Y; Wu Z; Xie R; Zeng F; Cai H; Lui S; Song B; Chen L; Wu M
Front Immunol; 2021; 12():790674. PubMed ID: 34899760
[TBL] [Abstract][Full Text] [Related]
20. Response Assessment in Neuro-Oncology Criteria for Gliomas: Practical Approach Using Conventional and Advanced Techniques.
Leao DJ; Craig PG; Godoy LF; Leite CC; Policeni B
AJNR Am J Neuroradiol; 2020 Jan; 41(1):10-20. PubMed ID: 31857322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
